TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

Joseph Thome, Ph.D.

Managing Director, Health Care - Biotechnology

Joseph Thome, Vice President, Health Care - Biotechnology

Joseph Thome is a managing director and senior research analyst on TD Cowen’s biotechnology team. Dr. Thome was selected as a “Rising Star in Equity Research” by Business Insider in 2021 and the TD Cowen biotechnology team has consistently been among the top-ranked teams in the Greenwich Survey.

Prior to joining TD Cowen in March 2016, Dr. Thome was an NIH pre-doctoral research fellow at Columbia University, studying the compartmentalization and maintenance of the human T cell immune response from infancy into adulthood. His research has been published in several prestigious journals including Cell and Nature Medicine.

Dr. Thome received a BA with high honors in chemistry and biochemistry from Oberlin College and a Ph.D. in microbiology and immunology from Columbia University, where he was granted the Dean’s Award for Excellence in Research.

Get In Touch

Start a conversation with Joseph Thome


    Explore related thought leadership, reports, coverage and insights for Joseph Thome.

    Ahead of the Curve®

    Back to School: Grading FDA Divisions on Regulatory Flexibility   

    A lightbulb planted in soil with a sprout growing from inside it representing our best ESG investment ideas for 2023.

    Best ESG Investment Ideas for 2023

    A variety of pharmaceuticals laid on top of a desk next to a calculator, representing our drug pricing outlook. Laid on top are a variety of pills of various colors.
    Ahead of the Curve®

    The Price Is (Not) Right: Discounts, 340B, Access, And IRA